Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Hodgkin Disease 7Carcinoma, Non-Small-Cell Lung 7Lymphoma 6Lung Neoplasms 6Recurrence 3Testicular Neoplasms 1Teratoma 1Pathologic Complete Response 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Mesothelioma, Malignant 1Lymphoma, Large-Cell, Anaplastic 1Kidney Neoplasms 1Glioma 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Etoposide 4Cisplatin 4Ifosfamide 3Filgrastim 3Carboplatin 3Bleomycin 3pegfilgrastim 2Paclitaxel 2lerisetron 1isophosphamide mustard 1Watchful Waiting 1Vinblastine 1Surveys and Questionnaires 1Sorafenib 1Radiotherapy 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Olanzapine 1Magnetic Resonance Spectroscopy 1Lenograstim 1Granisetron 1Gemcitabine 1Flow Cytometry 1Drug Therapy 1Dexamethasone 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Testicular Neoplasms × Vinblastine × Clear all
NCT00274950 2013-09-17

Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors

National Cancer Institute (NCI)

Phase 3 Unknown
105 enrolled
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡